WHO ICTRP trial
Optimizing periconceptional lifestyle of overweight women using a blended…
NL-OMON21869 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON21869 |
|---|---|
| Public title | Optimizing periconceptional lifestyle of overweight women using a blended personalized care intervention combining eHealth and Face-to-face coUnSEling: The Randomized Controlled eFUSE Trial |
| Scientific title | eFUSE: Optimizing periconceptional lifestyle of overweight women using a blended personalized care |
| Primary sponsor | Erasmus MC, University Medical Center Rotterdam |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | overweight |
| Interventions | Blended personalized periconception lifestyle approach, consisting of: 1. A periconception eHealth platform, providing personalized risk assessment and nutrition and lifestyle counselling via the evidence-based eHealth interventions… |
| Registration date | Feb 23, 2021 |
| Target size | 626 |
| Secondary IDs | NL9264;METC Erasmus MC : MEC-2020-0113 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: